Literature DB >> 2663983

Infections of CSF shunt and intracranial pressure monitoring devices.

J L Venes1.   

Abstract

Management of shunt infections varies, but externalization of shunt apparatus and the need for intraventricular antibiotics seem to have been rather uniformly adopted. No recent studies on EVD systems have been reported, largely because of the widespread use of alternatives such as the fiberoptic systems and the hollow subarachnoid bolt. Studies from the 1970s and personal experience with long-term monitoring in children with Reye's syndrome and head trauma indicate that it can be done safely with a low risk of infection. What the defining variable(s) for that low infection rate might be is not at all certain. Analysis of risk factors and the development of a study design that will provide statistically valid information must be accomplished before unbiased decisions can be made concerning the use of perioperative antibiotics in the management of CSF shunts. Until that is accomplished, the risks of such therapy must be carefully balanced against the possible (but unproven) benefit.

Entities:  

Mesh:

Year:  1989        PMID: 2663983

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  9 in total

Review 1.  Analysis of intracranial pressure.

Authors:  D J Doyle; P W Mark
Journal:  J Clin Monit       Date:  1992-01

2.  Few Patient, Treatment, and Diagnostic or Microbiological Factors, Except Complications and Intermittent Negative Cerebrospinal Fluid (CSF) Cultures During First CSF Shunt Infection, Are Associated With Reinfection.

Authors:  Tamara D Simon; Nicole Mayer-Hamblett; Kathryn B Whitlock; Marcie Langley; John R W Kestle; Jay Riva-Cambrin; Margaret Rosenfeld; Emily A Thorell
Journal:  J Pediatric Infect Dis Soc       Date:  2013-08-26       Impact factor: 3.164

Review 3.  Shunt Devices for Neurointensivists: Complications and Management.

Authors:  G Smith; J Pace; A Scoco; G Singh; K Kandregula; S Manjila; C Ramos-Estebanez
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

4.  Cerebrospinal Fluid Shunt Infection: Emerging Paradigms in Pathogenesis that Affect Prevention and Treatment.

Authors:  Tamara D Simon; Joshua K Schaffzin; Charles B Stevenson; Kathryn Willebrand; Matthew Parsek; Lucas R Hoffman
Journal:  J Pediatr       Date:  2018-12-06       Impact factor: 4.406

5.  Reinfection following initial cerebrospinal fluid shunt infection.

Authors:  Tamara D Simon; Matthew Hall; J Michael Dean; John R W Kestle; Jay Riva-Cambrin
Journal:  J Neurosurg Pediatr       Date:  2010-09       Impact factor: 2.375

6.  External ventricular drainage: indications and outcome among Sudanese Children.

Authors:  Mohammed Awad Elzain; Moayad Moawia Ahmed; Abubakr Darrag Salim
Journal:  Sudan J Paediatr       Date:  2022

7.  Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2018-02-02       Impact factor: 2.375

8.  Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy Gove; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatr       Date:  2016-09-28       Impact factor: 4.406

9.  Evaluation of microbial bacterial and fungal diversity in cerebrospinal fluid shunt infection.

Authors:  Tamara D Simon; Christopher E Pope; Samuel R Browd; Jeffrey G Ojemann; Jay Riva-Cambrin; Nicole Mayer-Hamblett; Margaret Rosenfeld; Danielle M Zerr; Lucas Hoffman
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.